By Margo Waldrop

Weight Watchers has outlasted diet fads, rebrands and even logic. But this time, it’s not carbs or keto that brought it down – it’s chemistry.

Earlier this month, Weight Watchers filed for bankruptcy. The company cited declining sign-ups, changing consumer behavior and the rapid ascent of GLP-1 drugs like Ozempic and Wegovy. The twist? Weight Watchers now sells those same drugs, having pivoted into telehealth with the acquisition of Sequence last year.

That wasn’t just a product move. It was a quiet admission that the original model – community-led, effort-driven, belief-based – no longer makes sense in a world where weight Read full story ›

Source: The Drum